Brief: Mithra Successfully Renegotiates Earnouts Relating To Its Complex Therapeutics

Mithra Pharmaceuticals SA

24/06/2021 16:52

June 24 (Reuters) - MITHRA PHARMACEUTICALS SA  MITRA.BR :
    * SUCCESSFULLY RENEGOTIATES EARNOUTS RELATING TO ITS COMPLEX
THERAPEUTICS AND ACQUIRES FULL LICENSING AND DISTRIBUTION RIGHTS
FOR ZORELINE
    * STRENGTHENING OF MITHRA'S DEVELOPMENT STRATEGY WITH
COMPLETE
BUYOUT OF ALL REMAINING CONTINGENT PAYMENTS OBLIGATION
(EARNOUTS) LINKED TO MYRING® AND ZORELINE®
    * FULL GLOBAL LICENSING AND DISTRIBUTION RIGHTS FOR
ZORELINE®
IMPLANT INDICATED FOR TREATMENT OF BREAST, PROSTATE CANCER AND
CERTAIN GYNECOLOGICAL DISORDERS
    * ZORELINE® REPRESENTS AN ATTRACTIVE BUSINESS OPPORTUNITY IN
A
MARKET EXCLUSIVELY DOMINATED BY ONE BRAND PRODUCT RECORDING
WORLDWIDE SALES HIGHER THAN EUR 700 MILLION WITH A 4,5 % GROWTH

Source text for Eikon:  ID:nNDL1zpWKR 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))